-transparent.png){kind=logo}
The prevalence of eosinophilia in 66 patients with rheumatoid arthritis receiving D-penicillamine was determined in a retrospective study. Eosinophilia occurred in 24%. The simultaneous occurrence of toxicity and eosinophilia occurred in 3%. In contrast, eosinophilia only occurred in 10% of those with suspected toxicity. The value of eosinophilia as a marker of toxicity is discussed.
Related Publications
J Edelman, and
K F Maguire, and
E T Owen
June 1984,
Annals of the rheumatic diseases,
J Edelman, and
K F Maguire, and
E T Owen
October 1979,
Sovetskaia meditsina,
J Edelman, and
K F Maguire, and
E T Owen
January 1979,
Scandinavian journal of rheumatology,
J Edelman, and
K F Maguire, and
E T Owen
January 1981,
The Journal of rheumatology. Supplement,
J Edelman, and
K F Maguire, and
E T Owen
February 1976,
Agents and actions,
J Edelman, and
K F Maguire, and
E T Owen
January 1982,
La Revue de medecine interne,
J Edelman, and
K F Maguire, and
E T Owen
January 1981,
Revue du rhumatisme et des maladies osteo-articulaires,
J Edelman, and
K F Maguire, and
E T Owen
January 1977,
Proceedings of the Royal Society of Medicine,
J Edelman, and
K F Maguire, and
E T Owen
August 1983,
Annals of the rheumatic diseases,
J Edelman, and
K F Maguire, and
E T Owen
January 1981,
The Journal of rheumatology. Supplement,
